Latest Stock Split Details
Key information about Celldex Therapeutics, Inc.'s most recent stock split
Split Date: 2019-02-11
Split Ratio: 1:15
Price Before Split: $0.32
Price After Split: $0.02
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 15.00 times fewer shares (a 1:15 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Celldex Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2019-02-11 | 1:15 | Yes | $0.32 | $0.02 |
| 2008-03-10 | 1:12 | Yes | $0.64 | $0.05 |
About Celldex Therapeutics, Inc.
Company overview and industry information
Celldex Therapeutics, Inc. (CLDX) operates in the Biotechnology industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Celldex Therapeutics, Inc. Summary